The Pink Sheet- This article looks at the impact of [...]
About CatalystAdminThis author has not yet filled in any details.
So far CatalystAdmin has created 118 blog entries.
In this article, Catalyst’s Jill Hartzler Warner provides context for [...]
New FDA Leadership Changes Priorities But Doesn’t Change Administration Regulations, Panel Discussion Says
Biotech Investing News— Biotech Investing News reporters this week covered [...]
J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan’s Job Cuts, Teva Turnaround, Biogen’s Cash, And Getting FDA-Friendly
The Pink Sheet - In this article, The Pink Sheet covers the [...]
Come and join us on Jan. 8 as Catalyst President [...]
A Catalyst-penned article on Trump’s deregulatory agenda has earned a [...]
Join us on Jan. 9 as Catalyst President Nancy Bradish [...]
By Nancy Bradish Myers Yahooooo! What a thrill it is [...]
Pharmaceutical Online- What do Commissioner Gottlieb’s recent statements on orphan [...]
Gene Therapy Milestones: Gilead’s Acquisition of Kite Pharma and FDA’s Novartis CAR-T Approval Signal an Advancing Gene Therapy Field; What Are Key Takeaways for Gene Therapy Companies?
By Nancy Bradish Myers, Anne McNickle and Jill Hartzler Warner [...]